As we reported, the Canadian government has approved changes to Canada’s pharmaceutical patent regime, including the introduction of patent term restoration and the replacement of the current summary proceedings under the Patented Medicines (Notice of Compliance) Regulations with full actions. The reforms were expected to come into force on July 1, 2017; however, media sources are now reporting a possible delay until Fall 2017.
Treaty/Act: CETA/Bill C-30 (An Act to implement the Comprehensive Economic and Trade Agreement between Canada and the European Union and its Member States and to provide for certain other measures)
Are you CETA ready? Contact Norton Rose Fulbright with all your CETA questions.
Text of the final Comprehensive Economic and Trade Agreement